• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

SKM terminates planned merger

Article

Radiology services company Radiologix will be on its own for a while. Its planned merger with Saunders Karp & Megrue (SKM), a bank specializing in private investments, has been canceled by SKM. Radiologix, which will remain a publicly traded company,

Radiology services company Radiologix will be on its own for a while. Its planned merger with Saunders Karp & Megrue (SKM), a bank specializing in private investments, has been canceled by SKM. Radiologix, which will remain a publicly traded company, derives most of its revenue from diagnostic imaging procedures conducted at 124 physician-owned or -operated imaging centers located in 18 states and the District of Columbia.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.